Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does RIVAROXABAN Cause Coronary artery occlusion? 58 Reports in FDA Database

Lower Your Cholesterol — The Natural Way

The Oxidized Cholesterol Strategy: a science-backed plan for heart health.

See the Strategy

According to the FDA Adverse Event Reporting System (FAERS), 58 reports of Coronary artery occlusion have been filed in association with RIVAROXABAN (Rivaroxaban). This represents 0.0% of all adverse event reports for RIVAROXABAN.

58
Reports of Coronary artery occlusion with RIVAROXABAN
0.0%
of all RIVAROXABAN reports
3
Deaths
36
Hospitalizations

How Dangerous Is Coronary artery occlusion From RIVAROXABAN?

Of the 58 reports, 3 (5.2%) resulted in death, 36 (62.1%) required hospitalization, and 3 (5.2%) were considered life-threatening.

Is Coronary artery occlusion Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for RIVAROXABAN. However, 58 reports have been filed with the FAERS database.

What Other Side Effects Does RIVAROXABAN Cause?

Gastrointestinal haemorrhage (20,041) Haemorrhage (6,571) Epistaxis (5,629) Rectal haemorrhage (4,501) Off label use (4,463) Haematuria (4,387) Upper gastrointestinal haemorrhage (4,247) Cerebrovascular accident (4,111) Anaemia (3,907) Acute kidney injury (3,735)

What Other Drugs Cause Coronary artery occlusion?

ADALIMUMAB (1,392) TICAGRELOR (370) CALCIUM\DEXTROSE\MAGNESIUM\SODIUM\SODIUM (296) ROSUVASTATIN (283) METOPROLOL (230) SACUBITRIL\VALSARTAN (204) ASPIRIN (190) RISANKIZUMAB-RZAA (181) EVOLOCUMAB (162) CLOPIDOGREL BISULFATE (155)

Which RIVAROXABAN Alternatives Have Lower Coronary artery occlusion Risk?

RIVAROXABAN vs RIVASTIGMINE RIVAROXABAN vs RIVOTRIL RIVAROXABAN vs RIZATRIPTAN RIVAROXABAN vs ROACTEMRA RIVAROXABAN vs ROCURONIUM

Related Pages

RIVAROXABAN Full Profile All Coronary artery occlusion Reports All Drugs Causing Coronary artery occlusion RIVAROXABAN Demographics